Lung Cancer Rx

Oncology News Central
  • 5.0 (3)
  • MEDICINE
  • UPDATED BIWEEKLY

LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama Birmingham’s O’Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit, cohost each episode. “We wanted to bridge the gap between provider communication and patient communication,” explains Dr. Singhi.

Episodes

  1. 12/05/2025

    “We Want to Stop the Gatekeeping of Information”: The Origin of LungCancerRx

    To cap off the first year of the LungCancerRx podcast, cohosts Aakash Desai, MD, MPH; Eric K. Singhi, MD; and Fawzi F. Abu Rous, MD, share how they first came together and what they see as their mission for the series moving forward. “I think we want to stop the gatekeeping of information,” Dr. Singhi explained.

    12 min

  2. 11/21/2025

    “Absolute Flood” of ADCs and Key Data Lead to “Good Challenges” in EGFR-Mutated NSCLC

    In this episode of LungCancerRx, Eric Singhi, MD, Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD, welcome Julia Rotow, MD to the conversation. “I think we’ve been very lucky, in the world of EGFR-mutated lung cancer, that it has gotten so complicated,” explains Julia Rotow, MD, clinical director of the Lowe Center for Thoracic Oncology and director of clinical research at the Dana-Farber Cancer Institute in Boston. Dr. Rotow explains how key data from the HARMONi, COMPEL, and MARIPOSA-2 studies and a wave of new treatment options on the horizon have led to “good challenges” in non-small cell lung cancer care.

    30 min

  3. 09/26/2025

    “It Unlocks This Whole World”: Better Understanding of Lung Cancer Is Generating Better Outcomes

    In this episode of LungCancerRx, the experts talk about key trials presented at the World Conference on Lung Cancer, and the rapidly shifting landscape in lung cancer treatment, which now can be treated as multiple different diseases. Cohost Eric Singhi, MD, is joined by Bruna Pellini, MD, Antonio Calles, MD, and Stephen Liu, MD.

    29 min

  4. 09/12/2025

    “Milestone” in EGFR-Positive NSCLC: The Importance of Options for Patient-Centered Care

    In this episode of LungCancerRx, the experts talk about the FLAURA2 and HARMONi data presented at the World Conference on Lung Cancer and what the findings mean for patients with EGFR-mutated non-small cell lung cancer (NSCLC). Recorded onsite in Barcelona, Spain, cohost Eric Singhi, MD, from Houston, Texas, is joined by Bruna Pellini, MD, from Moffitt Cancer Center and Research Institute in Tampa, Florida; Antonio Calles, MD, from Hospital General Universitario Gregorio Marañón in Madrid, Spain; and Stephen Liu, MD, from Lombardi Comprehensive Cancer Center of Georgetown University in Washington, DC.

    26 min

  5. 08/22/2025

    “What I Tell My Patients”: Making Sense of New Treatment Options in EGFR-positive NSCLC

    In this episode of LungCancerRx, Eric Singhi, MD, Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD, welcome back Christine M. Lovly, MD, PhD, to talk about the complexities of treating advanced EGFR-positive NSCLC. Dr. Lovely shares how she talks with patients about the latest data and recent trials.

    31 min

  6. 08/08/2025

    Say No to Jargon, Yes to Testing: Oncologists Face Tough Patient Conversations in NSCLC

    As oncologists stand on “the cutting edge” of neoadjuvant treatment for EGFR-mutated lung cancer, how should they conduct complex conversations with patients? Christine M. Lovly, MD, PhD, joins hosts Aakash Desai, MD, MPH; Eric K. Singhi, MD; and Fawzi F. Abu Rous, MD, for an honest discussion about current challenges.

    29 min

  7. 07/11/2025

    Empowered Choices: “The Most Important Conversations” Oncologists Can Have With NSCLC Patients

    When it comes to treatment decisions for patients with EGFR-mutated non-small cell lung cancer, “the most important conversations are not the data-driven ones, they are the relational ones,” says patient advocate Jill Feldman. In the second episode of the LungCancerRx video podcast, cohosts Fawzi F. Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit; Eric K. Singhi, MD, a thoracic oncologist in Houston; and Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O’Neal Cancer Center, ask Feldman about how physicians can better empower patients when making difficult therapy choices. “I started using ‘informed decision-making’ because you cannot have ‘shared decision-making’ if patients aren’t completely informed,” she explains.

    20 min

  8. 06/12/2025

    Empowered Voices: The Journey to Patient Advocacy

    In the first episode of the LungCancerRx video podcast, cohosts Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O'Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit; are joined by patient advocate Jill Feldman. They talk about her experience with lung cancer – both her own and her family members’ – and why it is so important for individual patients to be heard and placed at the center of care. Communication is key to maintaining that focus, and the hosts seek insights into how providers can be present during appointments and how patients cope.

    21 min
  • 8 Episodes

Ratings & Reviews

5
out of 5
3 Ratings

About

LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama Birmingham’s O’Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit, cohost each episode. “We wanted to bridge the gap between provider communication and patient communication,” explains Dr. Singhi.

Information

  • Creator
    Oncology News Central
  • Years Active
    2K
  • Episodes
    8
  • Rating
    Clean
  • Copyright
    © Copyright 2025 All rights reserved.
  • Show Website
    Lung Cancer Rx